Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 4/14/2016
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 2||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Arthralgia, Condition aggravated, Immobile, Laboratory test abnormal, Paralysis, Rheumatoid arthritis
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Other Medications: No other medications
Current Illness: Rheumatoid arthritis; Sjogren''s Syndrome
Diagnostic Lab Data: Physical examination, given a diagnosis of rheumatoid arthritis
CDC 'Split Type': WAES1604USA006608
Write-up:This spontaneous report as received from a currently 29 years old female patient who was a certified medical assistant (C.M.A.) refers to herself via a field employee. The patient''s concurrent conditions included Sjogren''s syndrome and rheumatoid arthritis. On unknown dates, the patient was vaccinated with a first and a second dose of GARDASIL and on an unknown date in 2007, she was vaccinated with a third dose of GARDASIL (doses, routes of administration, lot # and expiration dates were not provided). The patient did not take any concomitant medications. On an unknown date (reported as "several months" after the patient received the third dose in the GARDASIL series), she felt paralyzed due to severe joint pain all over her body. The patient also felt immobilized for an unspecified amount of time prior to receiving treatment with unspecified doses of methotrexate (manufacturer unknown), Sulfa and prednisone (manufacturer unknown) for an unspecified amount of time. On an unknown date, the patient had a follow up appointment with her physician where the physician ran some unspecified tests and gave a diagnosis of rheumatoid arthritis. The physician also told the patient that her rheumatoid arthritis was "dormant in her body" prior to receiving the GARDASIL series and the vaccine could have possibly triggered the rheumatoid arthritis. At the time of the report, the patient still had the rheumatoid arthritis, was on an unspecified dose of XELJANZ and was no longer on the treatment with methotrexate (manufacturer unknown), Sulfa and prednisone. The event of rheumatoid arthritis was considered to be disabling by the reporter. Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166